Evidence map›Paper›PMID 25098841›Full record

ReviewBioarchitecture2014

The role of vertebrate nonmuscle Myosin II in development and human disease.

Xuefei Ma, Robert S Adelstein

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Bioarchitecture, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00083499 (Mutations in Genes Associated With Pentalogy of Cantrell), which is not on this map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00083499 completednot on this map

Mutations in Genes Associated With Pentalogy of Cantrell

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2004 to 2019Enrolled59ConditionsPentalogy of Cantrell
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Non-muscle myosin II is a promising therapeutic target.Trends in pharmacological sciences · 2025
    Article
  4. Article
  5. Article
  6. Ventral body wall closure: Mechanistic insights from mouse models and translation to human pathology.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Non-Muscle Myosin II A: Friend or Foe in Cancer?International journal of molecular sciences · 2024
    Review
  11. Article
  12. Structure, regulation, and mechanisms of nonmuscle myosin-2.Cellular and molecular life sciences : CMLS · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Variants of the myosin interacting-heads motif.The Journal of general physiology · 2023
    Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Xuefei MaLaboratory of Molecular Cardiology; National Heart, Lung, and Blood Institute; National Institutes of Health; Bethesda, MD USA.
Robert S AdelsteinLaboratory of Molecular Cardiology; National Heart, Lung, and Blood Institute; National Institutes of Health; Bethesda, MD USA.
Laboratory of Molecular Genetics · PLNational Institutes of Health · US

Funding

The Role of Nonmuscle Myosin II in CytokinesisZIAHL004228 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ADELSTEIN, ROBERT · 2009 to 2019
$5.0M
Studying Pentalogy of Cantrell in Humans and MiceZIAHL004230 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ADELSTEIN, ROBERT · 2009 to 2019
$4.5M
Intramural NIH HHS
6 · The paper itself

Abstract

Three different genes each located on a different chromosome encode the heavy chains of nonmuscle myosin II in humans and mice. This review explores the functional consequences of the presence of three isoforms during embryonic development and beyond. The roles of the various isoforms in cell division, cell-cell adhesion, blood vessel formation and neuronal cell migration are addressed in animal models and at the cellular level. Particular emphasis is placed on the role of nonmuscle myosin II during cardiac and brain development, and during closure of the neural tube and body wall. Questions addressed include the consequences on organ development, of lowering or ablating a particular isoform as well as the effect of substituting one isoform for another, all in vivo. Finally the roles of the three isoforms in human diseases such as cancer as well as in syndromes affecting a variety of organs in humans are reviewed.

Indexed as

AnimalsCell AdhesionEmbryonic DevelopmentHumansMiceModels, AnimalMorphogenesisMyosin Type IINeoplasmsProtein IsoformsMyosin Type IIProtein IsoformsBody Wall ClosureCancerCell AdhesionCongenital Diaphragmatic HerniaCytokinesisDouble Outlet of Right VentricleKaryokinesisMYH9-RDNeuronal MigrationPentalogy of CantrellPlacental Vascular Formation

Identifiers

PMID25098841
PMCPMC4201603
OpenAlexW2011364474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.